A CRISPR Platform for Targeted In Vivo Screens.

Maranda, Vincent; Zhang, Yue; Vizeacoumar, Frederick S; Freywald, Andrew; Vizeacoumar, Franco J

Maranda, Vincent; Zhang, Yue; Vizeacoumar, Frederick S; Freywald, Andrew; Vizeacoumar, Franco J.

Affiliation

Maranda V; Division of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
Zhang Y; Division of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
Vizeacoumar FS; Department of Pathology, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
Freywald A; Department of Pathology, College of Medicine, University of Saskatchewan, Saskatoon, Canada. andrew.freywald@usask.ca.
Vizeacoumar FJ; Division of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, Canada. franco.vizeacoumar@usask.ca.

Methods Mol Biol ; 2614: 397-409, 2023.

Article in En | MEDLINE | ID: mdl-36587138

Subject(s)

CRISPR-Cas Systems; Neoplasms; Humans; CRISPR-Cas Systems/genetics; Clustered Regularly Interspaced Short Palindromic Repeats/genetics; Genome; Neoplasms/genetics; Tumor Microenvironment/genetics

Key words

CRISPR-Cas9 screen; In vivo screen; Pooled screen; Synthetic lethality

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Methods Mol Biol Journal subject: BIOLOGIA MOLECULAR Year: 2023 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google